U
TECH icon

UBS’s Bio-Techne TECH Stock Holding History

UBS’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.63M Sell
69,608
-11,980
-15% -$281K ﹤0.01% 3103
2014
Q2 		$1.89M Buy
81,588
+16,668
+26% +$368K ﹤0.01% 2917
2014
Q1 		$1.39M Sell
64,920
-32,104
-33% -$722K ﹤0.01% 3140
2013
Q4 		$2.3M Buy
97,024
+19,460
+25% +$422K ﹤0.01% 2679
2013
Q3 		$1.55M Sell
77,564
-22,780
-23% -$432K ﹤0.01% 2866
2013
Q2 		$1.73M Buy
+100,344
New +$1.67M ﹤0.01% 2700

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS's TECH Position: Q3 2014 in Review

UBS reduced its Bio-Techne (TECH) stake by 15% in Q3 2014, selling an estimated $281K and leaving 69,608 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

UBS first reported a position in TECH in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.3M in Q4 2013. 248 funds tracked by Wall St. Rank hold TECH as of Q3 2014.

  • UBS held 69,608 shares of Bio-Techne worth $1.63M as of Q3 2014.
  • UBS sold 11,980 Bio-Techne shares in Q3 2014, an estimated $281K.
  • Bio-Techne made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3103 holding.
  • UBS first reported a position in Bio-Techne in Q2 2013 and has held it in 6 quarters since.
  • UBS's Bio-Techne position peaked at $2.3M in Q4 2013.
  • 248 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.